Fingerprint
Dive into the research topics of 'Otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, for relapsed or refractory NHL patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
John M. Pagel, Stephen E. Spurgeon, John C. Byrd, Farrukh T. Awan, Ian W. Flinn, Mark C. Lanasa, Amy J. Eisenfeld, Scott C. Stromatt, Ajay K. Gopal
Research output: Contribution to journal › Article › peer-review